Trials / Terminated
TerminatedNCT00764842
Efficacy of the CLP® Hip - Retrospective
Post-Market Study: The Efficacy of the CLP® Hip
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 61 (actual)
- Sponsor
- Encore Medical, L.P. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Encore CLP® Hip stem | Subjects with osteoarthritis, rheumatoid arthritis or avascular necrosis of the natural femoral head who have received the Encore CLP® Hip stem and are willing to participate in the study. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2008-10-02
- Last updated
- 2011-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00764842. Inclusion in this directory is not an endorsement.